Skip to main content
An official website of the United States government
Government Funding Lapse

Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

IPVC 2024 - Presentations from ULACNet & CASCADE

Date Posted

Presentations from the DCP-funded NCI ULACNet and CASCADE Programs at the 2024 International Papillomavirus Conference

The 36th International Papillomavirus Conference & Basic, Clinical and Public Health Scientific Workshops (IPVC 2024) will be held in Edinburgh, UK, November 12-15, 2024. The theme is “Equitable, Evidence-Based Approaches to HPV Disease,” and sessions will be available on demand after the conference for those who registered. 

Learn more at https://ipvconference.org/
 

Schedule

Tuesday, November 12, 2024

Time Topic Location
14:45 - 15:45

Public Health Workshop 03

  • Cervical cancer screening implementation issues. Methods to overcome barriers, including self-sampling, etc. - Jennifer Smith
 Pentland Auditorium

Wednesday, November 13, 2024

Time Topic Location
15:30 - 16:30 

ULACNet and CASCADE Program Meeting for IPVC Attendees

  • Vikrant V. Sahasrabuddhe, Silvina Frech, Emma Brofsky
 Menteith Room
18:15 - 19:15 Clinical Science - Poster Discussion Session 01
  • Ecological Analyses of Cervical Fungal Communities: Association with Cervical Disease Progression, HPV and Physiological Status – Filipa Godoy-Vitorino
  • HPV Vaccine Responses In Children With HIV – Ann Duerr
 Station 3

Thursday, November 14, 2024

Time Topic Location
16:00 - 17:30

Special Interest Satellite Symposium (SISS)
‘ULACNet’ And ‘CASCADE: Equitable Partnerships for Clinical Trials on Pragmatic Interventions for HPV-Related Screening and Precancer Treatment in People Living with HIV 
Chairs: Vikrant V. Sahasrabuddhe & Leeya F. Pinder

  • Foundational vision, organizational linkages, and partnership development in ‘ULACNet’ and ‘CASCADE’ – Vikrant V. Sahasrabuddhe 
  • Innovations and technologies to improve and optimize cervical and HPV-related cancer screening and triage for persons living with HIV – Luisa L. Villa 
  • Capacity building for expanding anal cancer prevention clinical care delivery and clinical research efforts for persons living with HIV – Josefina Romaguera 
  • Implementation experiences for clinical trials on cervical cancer screening, triage and precancer treatment in persons living with HIV – Bothwell T. Guzha 
  • Horizontal and diagonal integration approaches for enhancing access to HPV/cervical cancer screening – Lameck Chinula 
  • Management of multi-institutional collaborations for HPV/cancer prevention clinical trials for persons living with HIV – Carla J. Chibwesha 
  • Bridging disciplines to foster effective implementation of collaborations for HPV/cervical cancer prevention research – Gad Murenzi 
  • Evaluating novel strategies to improve precancer treatment for PLWH in ULACNet and CASCADE – Leeya F. Pinder
 Moorfoot
16:00 - 17:30

Clinical Science - Oral Abstracts Session 06

  • Improved Cervical Cancer Screening Using HPV Type Restriction and Cycle Threshold: A Prospective Screening Cohort of Women With and Without HIV In Botswana – Rebecca Luckett
 Fintry Auditorium
17:35 - 18:35 Public Health - Poster Discussion Session 02
  • Prevalence of Anal High-Risk Human Papillomavirus in ULACNet-101: A Study of People Living with HIV in Puerto Rico And Mexico – Josefina Romaguera
 Station 1

Posters (Exhibition Area)

POSTER SHIFT 1 Tuesday, November 12th - Wednesday, November 13th

Public Health, Epidemiology and Implementation Science – HPV among high risk/special populations

  • Human Papillomavirus Positivity as a Metric for HRA Performance – Sonia Hernandez-Salazar
  • Study Design of ULACNet Trial 202: Optimization of Cervical Cancer Screening Among Women Living with HIV in Latin American Countries – Kimberly Isaacs-Soriano

POSTER SHIFT 2 Thursday, November 14th - Friday, November 15th

Clinical Research – HPV tests & biomarkers for early detection and management of cervical cancer and related precursors

  • Triage of hrHPV-Positive Cervical Specimens by Host Gene Methylation in Women Living with HIV: Results from the ULACNet ROCCHHA 202 Study – Luisa Villa

Public Health, Epidemiology and Implementation Science – Epidemiology: Natural History/Risk Factors

  • Association Between Tobacco Use and Oral HPV Infection Among Men Living with HIV – Alejandra Portillo 

Public Health, Epidemiology and Implementation Science – HPV among high risk/special populations

  • Oral HPV Prevalence by Genotype Among Men with HIV in Puerto Rico, Brazil, and Mexico – Julie Rathwell
  • Prevalence of anal high-risk HPV infection among users of Condesa Clinics in Mexico City – Aarón Osvaldo Rodriguez-Ojeda
  • Cervical And Anal High-Risk HPV Infection, And Disease Status, Among Women Living With HIV in The ULACNet-CAMPO Consortium – Josefina Romaguera

Public Health, Epidemiology and Implementation Science – Screening for HPV-related disease: implementation, evaluation and impact

  • Estudio Oportunidad: A Longitudinal Study among Women Living with HIV In Santo Domingo, Dominican Republic – Margaret Madeleine